Hydrochloric Acid → HCID 11648608, compound

Participants

Reaction Steps

({[1-(6-Methoxy-[1,5]naphthyridin-4-yl)-pyrrolidin-3-yl]-methyl-carbamoyl}-methyl)-carbamic acid tert-butyl ester (272 mg, 0.66 mmol) was dissolved in a minimum amount of chloroform and treated with 4N HCl in dioxane (3 mL). After stirring 1 h, the reaction mixture was concentrated to dryness and azeotroped with toluene. The resulting HCl salt (302 mg, 0.66 mmol) was dissolved in methanol/dichloromethane (8 mL, 1:3) and treated with triethylamine (0.46 mL, 3.3 mmol) and 3-Oxo-3,4-dihydro-2H -pyrido[3,2-b ][1,4]oxazine-6-carbaldehyde (117 mg, 0.66 mmol) and stirred for 72 hours. The solution was diluted with a small amount of methanol and treated with sodium borohydride (25 mg, 0.66 mmol.) After stirring 90 minutes, the reaction mixture was diluted with chloroform and poured into saturated aqueous sodium bicarbonate solution. The aqueous layer was extracted with chloroform. The combined organic layers were washed with brine, dried over magnesium sulfate, filtered, concentrated and chromatographed in chloroform/methanol/ammonia. The resulting solid was converted to a di-HCl salt of the title compound as an off-white solid (27 mg, 8.6%): LC-MS m/z 478 (M+H)+; 1H NMR (CDCl3, 400 MHz) δ 8.25 (d, 1H, J=6 Hz), 8.02 (d, J=9 Hz, 1H), 7.29 (m, 1H), 7.11 (d, J=9 Hz, 1H), 6.99 (d, J=8 Hz, 1H), 6.62 (d, J=6 Hz, 1H), 5.23 (m, 1H), 4.63 (m, 2H), 4.18 (m, 3H), 4.01 (m, 3H), 3.81 (m, 2H), 3.68 (s, 1H), 3.57 (s, 1H), 3.00 (s, 2H), 2.26 (m, 2H).

Provenance & Evidence